This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Tenon Medical, Inc.
11/10/2022
Thank you for standing by. You're currently on hold for the Tenon Medical third quarter 2022 financial results and corporate update conference call. At this time, we are assembling today's audience and we plan to be underway momentarily. We appreciate your patience. Please remain on the line.
Please stand by.
Greetings and welcome to the Tenon Medical third quarter 2022 financial results and corporate update conference call. As a reminder, this call is being recorded. Your hosts today are Steve Foster, Chief Executive Officer and President, and Stephen Van Dyck, Chief Financial Officer. Mr. Foster and Mr. Van Dyck will present results of operations for the third quarter entered September 30th, 2022 and provide a corporate update. A press release detailing the results was released today and is available on the investor relations section of our company's website, www.tenonmed.com. Before we begin the formal presentation, I would like to remind everyone that statements made on the call and webcast may include predictions, estimates, and other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, They are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements which reflect our opinions only as of the date of this presentation. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. Throughout today's discussion, we will attempt to present some important factors relating to our business that may affect our predictions. You should also review our most recent prospectus for a more complete discussion of these factors and other risks, particularly under the heading risk factors. At this time, I'll turn the call over to Tenon Medical's Chief Executive Officer, Steve Foster. Please go ahead, sir.
You're reading a preview of the TNON Q3 2022 earnings call.
Free account.